Industry News: Page 284

GE announces first patient dosed with new PET radiopharmaceutical

By AuntMinnie.com staff writers

GE Healthcare announced that the first patient has been dosed in a phase III trial underway in France with a new dopamine transporter PET imaging radiopharmaceutical.

March 27, 2022

MRI reveals early onset of autism

By AuntMinnie.com staff writers

The first MRI study comparing autism spectrum disorder (ASD) and fragile X syndrome in infants has demonstrated strikingly different patterns of brain and behavior development between the conditions, according to a study published March 25 in the American Journal of Psychiatry.

March 27, 2022

ITM promotes supply deal with Novartis for Pluvicto

By AuntMinnie.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich SE (ITM) highlighted its lutetium-177 supply deal with Novartis in the wake of the U.S. Food and Drug Administration's approval of the company's Pluvicto radioligand therapy.

March 24, 2022

U.S. Senate passes act to promote breast screening for veterans

By AuntMinnie.com staff writers

The U.S. Senate has passed the Making Advances in Mammography and Medical Options for Veterans Act, a bill drawn up to expand mammography screenings for disabled female veterans.

March 24, 2022

Broncus highlights study on virtual navigation system

By AuntMinnie.com staff writers

Software developer Broncus Medical highlighted a recent study published in the journal Respirology showing its Archimedes Virtual Bronchoscopic Navigation System is safe and effective for guiding the sampling of peripheral pulmonary lesions.

March 24, 2022

Hologic opens Innovation Center in France

By AuntMinnie.com staff writers

Hologic recently opened its Innovation Center in Aix-en-Provence, France, which follows the company's 2019 acquisition SuperSonic Imagine, based in the area.

March 23, 2022

Clarity launching trial for prostate cancer therapy

By AuntMinnie.com staff writers

Clarity Pharmaceuticals is launching an investigator-initiated trial that will focus on the use of its copper-64 (Cu-64)-labeled radiopharmaceutical, Cu-64 SAR-bisPSMA, in prostate cancer.

March 23, 2022

Perspectum touts liver biomarker's performance in study

By AuntMinnie.com staff writers

Perspectum is touting its LiverMultiScan biomarker's performance in improving autoimmune hepatitis management, the results were published on March 21 in the Lancet.

March 23, 2022

FDA approves Lu-177 PSMA-617 for prostate cancer treatment

By Will Morton

The U.S. Food and Drug Administration (FDA) has approved lutetium-177 (Lu-177) prostate-specific membrane antigen radioligand therapy for the treatment of patients with metastatic prostate cancer.

March 22, 2022

Nvidia unveils Clara Holoscan MGX at GTC 2022

By AuntMinnie.com staff writers

Nvidia has launched Clara Holoscan MGX, a hardware and software platform designed to support development and deployment of healthcare artificial intelligence (AI) applications, at this week's 2022 GPU Technology Conference (GTC).

March 22, 2022

Eckert & Ziegler partners with Alpha-9 Theranostics

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has agreed to supply lutetium-177 to the Canadian biotechnology firm Alpha-9 Theranostics for use in clinical trials.

March 22, 2022

Scanslated touts study on radiology reports for patients

By AuntMinnie.com staff writers

Radiology software developer Scanslated is highlighting results of a study showing its radiology reporting software may improve patient understanding and engagement. The findings were published recently in the Journal of the American College of Radiology.

March 22, 2022

Previous Page

Page 284 of 3558

Next Page